Guillaume Bouguéon
PhD
Surname / Name: Guillaume Bouguéon, PhD
Email: guillaume.bougueon@u-bordeaux.fr
Career history: Guillaume Bouguéon is a PhD. He started his Pharmacy’s studies in University of Lille 2 in 2007. He carry out his internship successively in the University Hospitals Centers of Poitiers, Angers an Bordeaux between 2011 and 2016, and chose to specialize in Pharmaceutical Technology. During his studies, he fulfil a Master 1 in Biochemistry and Molecular Biology in University of Lille 2 in 2010 and a Master 2 in Nanomedicine in University of Angers in 2014.
Education
Ph.D in Chemistry Sciences, 2020, University of Bordeaux, France
Doctor in Hospital Pharmacy, 2016, University of Poitiers, France
Master 2 in Nanomedicines, 2014, University of Angers, France
Research. Guillaume Bouguéon was a PhD Student, working on the formulation of nanosystems for 3D Bioprinting for tissue engineering. He has previously worked as part of his pharmacy thesis on the formulation of a topical sirolimus pharmaceutical coumpounding to treat facial angiofibromas of Tuberous Sclerosis. Throughout his Master 2 work placement he help with European Trans Int Project, by looking for the design of an oral peptide nanocarrier, in MINT laboratory, UMR-S 1066 in the CHU of Angers. He worked also in the virology laboratory of the Institut Pasteur de Lille, CNRS UMR 8161, on the impact of Epigallocatechine Gallate on the Hepatitis C virus assembly.
5 Recent works:
Micro- and Nano-formulations for bioprinting and additive manufacturing.
Guillaume Bouguéon, Tina Kauss, Bérangère Dessane, Philippe Barthélémy, Sylvie Crauste-Manciet.
Drug Discovery Today , 24 (1) 2019, 163-178.
Automation of aseptic sterile preparation: risk analysis and productivity comparison with manual process.
Jeanne Heloury, Guillaume Bouguéon, Thomas Deljehier, Aude Berroneau, Sylvie Crauste-Manciet. Pharmaceutical Technology in Hospital Pharmacy, 2019, 4(1): 15–28.
Simulation program of a cytotoxic compounding robot for monoclonal antibodies and anti-infectious sterile drug preparation.
Thomas Deljehier, Guillaume Bouguéon, Jeanne Heloury, Valérie Moreno, Aude Berroneau, Sylvie Crauste-Manciet.
Journal of Oncology Pharmacy Practices, 2019 Jan 16:1078155218823911.
Nucleotide lipid based hydrogels for biofabrication of 3D substitutes for transplantation of hematopoietic stem cells derives from human IPSCs
Bérangère Dessane, Guillaume Bouguéon, Raphaël Devillard, Julie Baillet, Murielle Remy, Aurélie Bedel, François Moreau-Gaudry, Philippe Gorry, Tina Kauss, Sylvie Crauste-Manciet, Philippe Barthélemy. 3rd Workshop on Regenerative Medicine, BxCRM, 14-16 novembre 2018, Bordeaux
Formulation and characterization of a 0.1 % rapamycin cream for the treatment of Tuberous Sclerosis Complex cutaneous injuries.
G.Bouguéon, S.Vrignaud, H.Pailhoriès, G.Bastiat, L.Martin, F.Lagarce.
International Journal of Pharmaceutics, 509 (2016) 279–284.